| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2663 | 2019 |
| 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 825 | 2017 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 684* | 2021 |
| Molecular mechanisms linking oxidative stress and diabetes mellitus H Yaribeygi, T Sathyapalan, SL Atkin, A Sahebkar Oxidative medicine and cellular longevity 2020 (1), 8609213, 2020 | 650 | 2020 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 616 | 2019 |
| Potential effects of curcumin in the treatment of COVID‐19 infection F Zahedipour, SA Hosseini, T Sathyapalan, M Majeed, T Jamialahmadi, ... Phytotherapy Research 34 (11), 2911-2920, 2020 | 361 | 2020 |
| Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial JR Petrie, N Chaturvedi, I Ford, MCGJ Brouwers, N Greenlaw, T Tillin, ... The lancet Diabetes & endocrinology 5 (8), 597-609, 2017 | 359 | 2017 |
| Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial O Mosenzon, TM Blicher, S Rosenlund, JW Eriksson, S Heller, OH Hels, ... The lancet Diabetes & endocrinology 7 (7), 515-527, 2019 | 308 | 2019 |
| High‐cocoa polyphenol‐rich chocolate improves HDL cholesterol in Type 2 diabetes patients DD Mellor, T Sathyapalan, ES Kilpatrick, S Beckett, SL Atkin Diabetic medicine 27 (11), 1318-1321, 2010 | 225 | 2010 |
| Mediators of inflammation in polycystic ovary syndrome in relation to adiposity T Sathyapalan, SL Atkin Mediators of inflammation 2010 (1), 758656, 2010 | 185 | 2010 |
| Effects of curcumin on mitochondria in neurodegenerative diseases H Bagheri, F Ghasemi, GE Barreto, R Rafiee, T Sathyapalan, A Sahebkar Biofactors 46 (1), 5-20, 2020 | 183 | 2020 |
| The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study T Sathyapalan, ES Kilpatrick, AM Coady, SL Atkin The Journal of Clinical Endocrinology & Metabolism 94 (1), 103-108, 2009 | 181 | 2009 |
| Curcumin: a modulator of inflammatory signaling pathways in the immune system KR Kahkhaie, A Mirhosseini, A Aliabadi, A Mohammadi, MJ Mousavi, ... Inflammopharmacology 27, 885-900, 2019 | 180 | 2019 |
| Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists … H Deshmukh, EG Wilmot, R Gregory, D Barnes, P Narendran, S Saunders, ... Diabetes Care 43 (9), 2153-2160, 2020 | 179 | 2020 |
| Effect of COVID‐19 on mortality of pregnant and postpartum women: a systematic review and meta‐analysis L Karimi, S Makvandi, A Vahedian-Azimi, T Sathyapalan, A Sahebkar Journal of pregnancy 2021 (1), 8870129, 2021 | 164 | 2021 |
| Sporopollenin, the least known yet toughest natural biopolymer G Mackenzie, AN Boa, A Diego-Taboada, SL Atkin, T Sathyapalan Frontiers in Materials 2, 66, 2015 | 161 | 2015 |
| High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome T Sathyapalan, S Beckett, AS Rigby, DD Mellor, SL Atkin Nutrition journal 9, 1-5, 2010 | 149 | 2010 |
| The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind … T Sathyapalan, AM Manuchehri, NJ Thatcher, AS Rigby, T Chapman, ... The Journal of Clinical Endocrinology & Metabolism 96 (5), 1442-1449, 2011 | 148 | 2011 |
| Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits Z Javed, T Sathyapalan Therapeutic advances in endocrinology and metabolism 7 (1), 12-23, 2016 | 144 | 2016 |
| Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause T Sathyapalan, M Aye, AS Rigby, NJ Thatcher, SR Dargham, ES Kilpatrick, ... Nutrition, Metabolism and Cardiovascular Diseases 28 (7), 691-697, 2018 | 134 | 2018 |
